Related Experiment Video
Updated: Jun 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies
Christophe Meune1, Olivier Vignaux, André Kahan
1Service de cardiologie, hôpital Cochin, AP-HP, université Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. christophe.meune@cch.aphp.fr
Insights
Systemic sclerosis frequently causes heart problems, leading to fibrosis. Early detection through advanced imaging and biomarkers like B-type natriuretic peptides is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Rheumatology
- Medical Imaging
Background:
- Heart involvement, particularly primary myocardial issues, is prevalent in systemic sclerosis.
- This cardiac involvement is linked to repeated focal ischemic injury, resulting in irreversible myocardial fibrosis.
- Clinically apparent cardiac issues indicate a poor prognosis, underscoring the need for early detection.
Purpose of the Study:
- To highlight the commonality and severity of cardiac involvement in systemic sclerosis.
- To emphasize the importance of preclinical identification of heart involvement.
- To review current and advanced diagnostic modalities for assessing cardiac function and structure.
Main Methods:
- Echocardiography, including pulsed tissue Doppler echocardiography, is the standard for cardiac assessment.
- Single photon emission computed tomography (SPECT) can evaluate myocardial perfusion.
- Cardiac magnetic resonance imaging (CMR) offers comprehensive assessment of volumes, function, perfusion, inflammation, and fibrosis.
Main Results:
- Systemic sclerosis commonly affects the heart, leading to myocardial fibrosis via ischemic injury.
- Advanced imaging techniques like echocardiography, SPECT, and CMR are vital for detailed cardiac evaluation.
- Biomarkers such as B-type natriuretic peptides are valuable indicators of global heart involvement.
Conclusions:
- Early and accurate detection of cardiac involvement in systemic sclerosis is critical due to its poor prognostic implications.
- A multimodal approach combining imaging (echocardiography, CMR) and biomarkers (BNP) is recommended for comprehensive patient assessment.
- These methods aid in screening patients and advancing research on systemic sclerosis-related heart disease.
Abstract:
Heart involvement, including primary myocardial involvement, is very common in systemic sclerosis. There is strong evidence that primary myocardial involvement is related to repeat focal ischaemic injury causing subsequent irreversible myocardial fibrosis. Clinically evident cardiac involvement is recognized to be a poor prognostic factor; thus preclinical identification is highly encouraged. The severity of heart involvement has been confirmed recently. Echocardiography, including pulsed tissue Doppler echocardiography, is the cornerstone of routine heart assessment. Myocardial perfusion may be assessed by single photon emission computed tomography. If available, cardiac magnetic resonance imaging should be considered as it allows simultaneous measurement of ventricular volumes and function and myocardial perfusion, and assessment of possible inflammation and/or fibrosis. Biological variables, such as B-type natriuretic peptides, are highly relevant, valuable markers of global heart involvement in systemic sclerosis and should be considered for screening of patients and/or research purposes.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Myocarditis II: Clinical Features and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
